MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
Aethlon Medical ROA Ratio 2011-2026 | AEMD
Annual ROA Ratio Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -181.91 | -148.05 | -68.71 | -53.64 | -73.92 | -61.36 | -150.25 | -77.25 | -421.47 | -190.57 | -492.34 | -787.99 | -984.92 | -967.14 | -1006.92 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -53.64 | -1006.92 | -377.76 |
Quarterly ROA Ratio Aethlon Medical
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -105.45 | -107.3 | -118.72 | -81.14 | -114.36 | -120.67 | -112.6 | -77.64 | -91.39 | -71.93 | -64.79 | -47.23 | -58.76 | -56.53 | -67.78 | -47.41 | -66.69 | -74.45 | -91.06 | -75.43 | -84.01 | -82.23 | -55.35 | -176.61 | -238.48 | -261.64 | -284.8 | -178.21 | -128.88 | -109.34 | -182.46 | -496.64 | -649.35 | -780.92 | -1255.08 | -1040.74 | -1074.62 | -955.8 | -444.89 | -151.21 | -200.33 | -215.57 | -681.15 | -985.22 | -1091.19 | -1148.03 | -2036.32 | -3407.95 | -3305.71 | -3097.51 | -2114.28 | -641.88 | -705.52 | -871.41 | -1542.23 | -2125.82 | -63.64 | -1118.49 | -943.69 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -47.23 | -3407.95 | -619.98 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-1226.84 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Xtant Medical Holdings
XTNT
|
-17.53 | $ 0.55 | -2.31 % | $ 73.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-70.61 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
85.61 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-151.34 | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
4.23 | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
-18.12 | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-0.34 | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-67.55 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
2.02 | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-102.09 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-43.74 | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
7.84 | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-1.64 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-7.8 | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
-2.67 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-159.57 | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-40.31 | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
9.73 | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
16.03 | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
-41.77 | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
1.82 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-20.48 | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
-77.74 | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
-10.62 | - | - | $ 6.6 M | USA |
 |
GBS
GBS
|
-128.11 | - | -0.57 % | $ 7.12 M | USA |
 |
AVITA Medical
RCEL
|
-86.16 | $ 3.82 | -1.04 % | $ 106 M |  Australia |
 |
AxoGen
AXGN
|
-7.08 | $ 31.28 | -3.01 % | $ 1.44 B | USA |
 |
Delcath Systems
DCTH
|
2.18 | $ 8.97 | -1.75 % | $ 321 M | USA |